Alzheimer Disease Clinical Trial
Official title:
Effects of Exercise on Cognitive Performance of Patients With Alzheimer-type Dementia. Pilot Study.
A program that combines high intensity aerobic exercise (<85% of Heart Rate Reserve) with
resistance, progressive and moderate intensity intervals, carried out in primary care, is
effective in terms of a smaller increase in respect to the baseline measurement in the total
score of the ADAS cognitive section (Alzheimer Disease Assessment Scale-Cognitive
section),in the control group that receives an intervention similar to low intensity (30-40%
of Heart rate reserve).
We Expect a difference of at least 3 points between the means of the increments between the
intervention and control group.
OBJECTIVE: To evaluate an intervention that combines high intensity aerobic exercise with
strength (AAAD) on general cognitive performance of patients affected by mild Alzheimer's
disease (AD). DESIGN: Randomized clinical trial in two parallel groups: SCOPE: 2 health
center of Basque Health Service , in coordination with its reference neurology services.
PARTICIPANTS: 80 patients with mild AD.
INTERVENTION: Both groups receiving standard drug treatment. The intervention group also
receive a supervised EEAA program, while the control group receive a similar intervention at
low intensity. Patients are followed up over 1 year. Three blind measurements are made
repeatedly : baseline, at 6 and 12 months. MEASUREMENTS: The primary outcome measure is
change in cognitive performance that is measured in a blinded way with the cognitive section
of the ADAS scale (Alzheimer's Disease Assessment Scale) at 0, 6 and 12.Secondary Outcomes:
Global cognitive performance (Neuropsychological battery TBR-B),neuropsychiatric symptoms
(NPI), ADL (Blessed),functional capacity (Test of 6-minute walk), cardiorespiratory Test,
muscular strength (hand dynamometer and trunk); PREDICTORS AND CONFOUNDING VARIABLES:
baseline cognitive performance, previous physical activity, medication, age, sex, APOE,
schooling and cognitive reserve. ANALYSIS: We compared the two groups in terms of observed
mean changes from baseline in ADAS measurement and other variables, intention to treat,
using longitudinal mixed effects models for repeated measures at 6 and 12 months.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |